Orforglibron, a pill form of GLP-1 weight loss injections like Ozempic and Mounjaro, is undergoing clinical trials. Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes ...

Ozempic has become somewhat of a buzzword in the Western beauty sphere, making its way from the NHS shelves to Hollywood red carpets. Originally developed as a once-weekly injection for type 2 ...

Poor tolerability of GLP-1 obesity drugs leads many patients to stop taking them, resulting in gaining back the weight that was lost. Some drug companies are trying to develop other approaches that ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

FDA's new voucher could shorten drug review to 1-2 months Lilly's orforglipron targets high-burden chronic condition Analysts predict price erosion due to new market entrants Sept 16 (Reuters) - Eli ...

If approved, the pill is expected to be far easier to administer than current injectables - and far easier to manufacture Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its ...

A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study. Taken at the highest dose, orforglipron helped patients lose an average 27.3 pounds, or 12 ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...